V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330006197 | 330002978 | 0.89 | null | Neo-adjuvant (N) | 2016-08-02 | 2016-08-12 | NB HRNBL-1 COJEC Ind COURSE B | N | N | 330000222 | NOT MATCHED |
| 330006198 | 330002978 | 1.7 | null | Curative (C) | 2015-06-07 | 2015-07-01 | Cisplatin 100 + RT(H&N) 1 day | N | N | 330000222 | CISPLATIN + RT |
| 330006199 | 330002978 | null | 6.7 | Neo-adjuvant (N) | 2014-01-31 | 2014-02-13 | NB HRNBL-1 TVD | N | N | 330000222 | NOT MATCHED |
| 330006200 | 330002980 | 0 | 32 | Curative (C) | 2014-07-05 | 2014-07-05 | NB HRNBL-1 BUMEL MAT | 02 | N | 330000236 | NOT MATCHED |
| 330006201 | 330002981 | 0.98 | 14.1 | Disease modification (D) | null | 2014-05-05 | NB Relapsed CCLG guidelines TVD | 2 | null | 330000242 | NOT MATCHED |
| 330006202 | 330002987 | null | 19.9 | Curative (C) | 2016-09-29 | 2016-09-30 | NB HRNBL-1 COJEC Ind COURSE C | N | null | 330000247 | NOT MATCHED |
| 330006203 | 330011544 | 1.82 | 94.6 | null | 2014-12-04 | 2014-12-12 | NB HRNBL-1 ch14.18/CHO(trial) +IL-2 | N | N | 330000258 | NOT MATCHED |
| 330006204 | 330002990 | 0 | 55.3 | Palliative (P) | 2013-06-25 | 2013-10-03 | NB HRNBL-1 COJEC Ind COURSE B | null | N | 330000262 | NOT MATCHED |
| 330006205 | 330002991 | 0 | 12.8 | Palliative (P) | 2016-04-18 | 2016-11-06 | CNS LGG 2004 03 cons vinc + carbo | N | null | 330000263 | NOT MATCHED |
| 330006206 | 330010140 | 0 | 16.8 | Curative (C) | 2016-03-15 | 2016-03-15 | WT SIOP 2002 01 post op Carbo, Etop | null | null | 330000276 | NOT MATCHED |
| 330006207 | 330002996 | null | null | Palliative (P) | 2014-12-25 | 2015-04-23 | NB HRNBL-1 COJEC Ind COURSE A | N | N | 330000277 | NOT MATCHED |
| 330006208 | 330002997 | 1.04 | 15.3 | Curative (C) | 2015-11-12 | 2016-04-19 | NB HRNBL-1 COJEC Ind COURSE B | 02 | Y | 330000287 | NOT MATCHED |
| 330006209 | 330002998 | null | 8.6 | Curative (C) | 2015-08-15 | 2015-08-22 | NB Rel GD2ch14.18/CHO, IL-2 Isotret | 02 | N | 330000287 | NOT MATCHED |
| 330006210 | 330010142 | 0 | 59.2 | Curative (C) | 2015-04-01 | 2015-04-01 | NB Rel CCLG guidelines Irin & Temoz | N | Y | 330000299 | NOT MATCHED |
| 330006211 | 330003002 | 0 | 67.7 | Curative (C) | 2014-05-19 | 2014-06-22 | CNS LGG 2004 03 cons vinc + carbo | N | Y | 330000305 | NOT MATCHED |
| 330006212 | 330003004 | null | 13.4 | Curative (C) | 2013-07-17 | 2013-07-21 | NB HRNBL-1 COJEC Ind COURSE B | 02 | N | 330000305 | NOT MATCHED |
| 330006213 | 330011548 | null | 73 | Curative (C) | 2018-05-24 | 2018-05-24 | CYCLOPHOSPHAMIDE + CYTARABINE + MERCAPTOPURINE + METHOTREXATE | N | Y | 330000310 | NOT MATCHED |
| 330006214 | 330003005 | 0.99 | 16.1 | Palliative (P) | 2018-01-07 | 2018-01-18 | NB Rel CCLG guidelines Cyclo-Topotecan | 02 | N | 330000310 | NOT MATCHED |
| 330006215 | 330003005 | 1.8 | 11.9 | Neo-adjuvant (N) | 2015-01-31 | 2015-05-19 | NB HRNBL-1 ch14.18/CHO only (trial) | 2 | N | 330000310 | NOT MATCHED |
| 330006216 | 330003006 | 1.66 | 4.8 | Curative (C) | 2014-05-16 | 2014-05-16 | NB Rel GD2ch14.18/CHO, IL-2 Isotret | N | Y | 330000334 | NOT MATCHED |
| 330006217 | 330012996 | 0 | null | Neo-adjuvant (N) | 2016-06-25 | 2016-06-30 | NB HRNBL-1 COJEC Ind COURSE B | null | N | 330000353 | NOT MATCHED |
| 330006218 | 330003011 | null | 26 | Curative (C) | 2016-10-25 | 2017-02-23 | NB HRNBL-1 TVD | N | Y | 330000353 | NOT MATCHED |
| 330006219 | 330003012 | 1.67 | 12.2 | Curative (C) | 2016-08-26 | 2016-08-26 | CYCLOPHOSPHAMIDE + CYTARABINE + MERCAPTOPURINE + METHOTREXATE | N | N | 330000369 | NOT MATCHED |
| 330006220 | 330003013 | 1.78 | null | Curative (C) | null | 2013-02-12 | EW EuroEwing 2012 Arm B VC | null | null | 330000382 | NOT MATCHED |
| 330006221 | 330007609 | 0.98 | 11.9 | Curative (C) | 2015-04-02 | 2015-04-16 | NB HRNBL-1 Isotretinoin | 02 | null | 330000388 | NOT MATCHED |
| 330006222 | 330007609 | null | null | Curative (C) | 2012-11-03 | 2013-11-20 | NB HRNBL-1 Isotretinoin | N | Y | 330000388 | NOT MATCHED |
| 330006223 | 330007609 | null | 66.4 | Neo-adjuvant (N) | 2017-10-03 | 2017-10-03 | CISPLATIN + RT | N | Y | 330000388 | CISPLATIN + RT |
| 330006224 | 330003015 | 1.87 | 58.5 | Curative (C) | 2013-09-07 | 2013-10-25 | CISPLATIN + RT | 02 | Y | 330000390 | CISPLATIN + RT |
| 330006225 | 330007611 | 0 | 73 | Neo-adjuvant (N) | null | 2017-04-21 | EW EuroEwing 2012 Arm A VAC | N | null | 330000392 | NOT MATCHED |
| 330006226 | 330003020 | 1.85 | 59.2 | Curative (C) | 2016-04-02 | 2016-04-30 | Cisplatin + Radiotherapy | 02 | Y | 330000393 | CISPLATIN + RT |
| 330006227 | 330007613 | 0.99 | 92 | Neo-adjuvant (N) | 2015-11-07 | 2015-11-07 | NB HRNBL-1 TVD | N | null | 330000394 | NOT MATCHED |
| 330006228 | 330003021 | 1.7 | 97.3 | 1 | 2017-01-09 | 2017-02-05 | CISPLATIN + RT | 2 | null | 330000395 | CISPLATIN + RT |
| 330006229 | 330003021 | 0 | 0 | Curative (C) | 2017-07-16 | 2017-07-20 | NB HRNBL-1 COJEC Ind COURSE B | N | Y | 330000395 | NOT MATCHED |
| 330006230 | 330007615 | 1.71 | null | Adjuvant (A) | 2016-01-12 | 2016-01-12 | Cisplatin + Radiotherapy | 02 | Y | 330000397 | CISPLATIN + RT |
| 330006231 | 330011553 | 1.68 | 89.5 | Curative (C) | 2014-11-23 | 2014-11-29 | Cisplatin + Radiotherapy | 02 | null | 330000407 | CISPLATIN + RT |
| 330006232 | 330003024 | 1.82 | 129.3 | Curative (C) | null | 2015-12-31 | CISPLATIN + RT | 02 | Y | 330000409 | CISPLATIN + RT |
| 330006233 | 330003025 | 1.8 | 57 | Curative (C) | 2014-01-03 | 2014-03-03 | CISPLATIN + RT | N | Y | 330000410 | CISPLATIN + RT |
| 330006234 | 330003030 | 1.67 | null | Adjuvant (A) | 2015-01-27 | 2015-02-24 | CISPLATIN + RT | N | N | 330000426 | CISPLATIN + RT |
| 330006235 | 330003031 | 1.65 | 86.4 | Curative (C) | 2017-05-21 | 2017-06-23 | Cisplatin + Radiotherapy | 2 | Y | 330000429 | CISPLATIN + RT |
| 330006236 | 330003032 | 0.8 | 55 | Curative (C) | null | 2015-07-04 | NB HRNBL-1 BUMEL MAT | 2 | null | 330000450 | NOT MATCHED |
| 330006237 | 330003034 | 1.67 | 95 | Curative (C) | 2013-08-21 | 2013-09-08 | Cisplatin 100 + RT(H&N) 1 day | N | Y | 330000451 | CISPLATIN + RT |
| 330006240 | 330003035 | null | 60 | Radical (R) | 2013-08-05 | 2013-10-31 | CISPLATIN + RT | null | N | 330000488 | CISPLATIN + RT |
| 330006241 | 330003036 | 1.69 | 113 | null | 2017-04-01 | 2017-04-01 | Cisplatin + Radiotherapy | N | N | 330000490 | CISPLATIN + RT |
| 330006242 | 330003036 | null | 62.1 | Curative (C) | null | 2014-09-03 | Cisplatin + Radiotherapy | N | Y | 330000490 | CISPLATIN + RT |
| 330006243 | 330010155 | null | 63 | Curative (C) | 2015-06-24 | 2015-06-24 | CISPLATIN + RT | 02 | N | 330000498 | CISPLATIN + RT |
| 330006244 | 330003037 | 1.85 | 81.8 | Adjuvant (A) | 2017-03-27 | 2017-06-09 | CISPLATIN + RT | N | N | 330000509 | CISPLATIN + RT |
| 330006245 | 330003038 | null | 11.6 | Curative (C) | null | 2015-03-09 | NB HRNBL-1 BUMEL MAT | 02 | N | 330000511 | NOT MATCHED |
| 330006246 | 330003040 | 1.35 | 11.4 | Curative (C) | 2014-01-04 | 2014-01-22 | NB HRNBL-1 ch14.18/CHO(trial) +IL-2 | N | N | 330000512 | NOT MATCHED |
| 330006247 | 330003041 | 1.73 | 69.7 | Curative (C) | 2014-05-19 | 2014-05-20 | Cisplatin 100 + RT(H&N) 1 day | 2 | N | 330000512 | CISPLATIN + RT |
| 330006248 | 330003042 | 0.98 | 37.2 | Palliative (P) | 2013-07-01 | 2013-07-04 | STS Rhabdomyosarcoma RMS 2005 IVAVV | 02 | null | 330000516 | NOT MATCHED |